Introduction
of monocytes, and ultimately take up transcytosed, modified lipoproteins (Lp) and turn into foam cells. Like all cells of the vessel wall, SMC are exposed to AGE-LDL that accumulates in the atheroma of diabetic patients
and animal models of diabetes [9] ; the specific effects of AGE-LDL on SMC are not known.
The involvement of the oxidative stress and the NADPH oxidase complex (NADPHox) in the dysfunction of vascular cells is well established [10, 11] . It is known that oxidized LDL (oxLDL) regulates the expression of NADPHox in human endothelial cells and vascular human SMC (hSMC) [12] , but there are no data on the effect of AGE-LDL on the modulation of NADPHox in hSMC.
The expression of native LDL receptors on arterial cells is tightly controlled and feedback regulated, in contrast to the uncontrolled uptake of modified LDL and subsequent foam cell formation occurring via alternative receptors (CD36, LRP1, scavenger receptors A and B1
, and RAGE) [13] ; there are no data on the effect of AGE-LDL on these receptors. [14] . The effects of AGE-LDL on MCP-1 expression are also not known.
MCP-1 is a potent pro-inflammatory chemokine, whose expression in hSMC is up-regulated by high glucose, leading to increased monocyte-SMC adhesive interactions

In this study, we provide evidence that AGE-LDL activates hSMC (inducing LRP1, CD36, RAGE), triggering a pro-oxidant state (activation of NADPHox) and pro-inflammatory state (expression of MCP-1) and lipid accumulation. To the best of our knowledge, this is the first report on the effects of AGE-LDL on vascular hSMC, providing a mechanism that may explain accelerated atherosclerosis in diabetic patients.
Materials and methods
Preparation of AGE-LDL
LDL was isolated from the plasma of healthy donors from the Blood
Transfusion Center Bucharest by density gradient ultracentrifugation as previously described [15] . The (24 hrs, at 37ЊC) 
LDL fraction was collected, dialysed against phosphate buffer saline (PBS), pH 7.4, 4ЊC in the dark, stored in sterile conditions in the presence of antioxidants (1 mg/ml EDTA and 10 M BHT) at 4ЊC and used within 7 days. AGE-LDL was prepared by incubation of nLDL (2 mg protein/ml) with D(ϩ)glucose (0.2M final concentration), for 4 weeks, at 37ЊC, under sterile conditions with antioxidants (1 mg/ml EDTA and 10 M BHT). Prior to the experiments, AGE-LDL was extensively dialysed against PBS, pH 7.4, 4ЊC. OxLDL was prepared by incubating nLDL under sterile conditions with 10 M copper chloride
Characterization of AGE-LDL
Quantification of the free, non-glycated amino groups was done using the trinitrobenzene sulphonic acid assay (TNBSA) [16] . [23] .
Lipid loading induced by AGE-LDL
Determination of NADPH oxidase activity
Quiescent hSMC were exposed for 24 hrs to 100 g/ml AGE-LDL, nLDL or oxLDL. The NADPH activity was determined in cell homogenates by lucigenin-enhanced chemiluminescence assay [24] using a low concentration of lucigenin (5 mol/l) to oxLDL minimize artifactual O2 Ϫ production due to redox cycling [25] . (Fig. 1D) (Fig. 2A) . Fig. 4 A-C) or oxLDL (Fig. 4D) (Fig. 5A) . (Fig. 5B) .
Quantification of reactive oxygen species (ROS)
Results
Characterization of AGE-LDL
Modulation of intracellular ROS production
AGE-LDL induces lipid loading of hSMC
considerably increased number of fluorescent lipid droplets in cells incubated with AGE-LDL compared to control cells or cells incubated with nLDL (
LDL receptors, CD36 and RAGE gene expression
The gene expression of LDL-R, LRP1, CD36 and RAGE in hSMC incubated with AGE-LDL or nLDL for 24 hrs was quantified by quantitative PCR. The gene expression of LDL-R was significantly inhibited by exposure of cells both to nLDL (18 Ϯ 2, P Ͻ 0.001) and to AGE-LDL (28 Ϯ 7, P Ͻ 0.01), compared to control hSMC (considered 100)
The LRP1 gene expression increased 2.6-fold (172 Ϯ 43, P Ͻ 0.05) in AGE-LDL-exposed cells compared to cells incubated with nLDL (65 Ϯ 33)
AGE-LDL determined an increase of the gene expression for scavenger receptor CD36 with 35% (169 Ϯ 11, P Ͻ 0.05)
Fig. 1 Characterization of AGE-LDL. Comparative evaluation of native LDL (nLDL), copper-oxidized LDL (oxLDL) and AGE-LDL (obtained by incubation of nLDL with 0.2M D(ϩ)glucose for 4 weeks). The glycated epitopes were measured by TNBSA (A) and TBA (B) assays, pentosidine and FFI levels (C), *P Ͻ 0.05, **P Ͻ 0.01, n ϭ 4, and the electronegative charge in 0.6% agarose gel electrophoresis (Oil Red O staining) (D).
Fig. 2 Oxidative stress induced by AGE-LDL incubation with hSMC. NADPH oxidase activity (A) was measured by lucigenin-enhanced chemiluminiscence (A), and reactive oxygen species (ROS) production by dichlorofluoresceine assays (B). 100 g protein/ml AGE-LDL, oxidized LDL (oxLDL) or native LDL (nLDL) were incubated 24 hrs with hSMC. Control, cells not exposed to LDLs, *P Ͻ 0.05, n ϭ 3.
Fig. 3 AGE-LDL up-regulates NADPH oxidase subunits expression in hSMC. Expression of mRNA obtained by Real-time PCR for NOX1 (A), NOX4 (B), p22phox (C) and p67phox (D) relative to control cells, not exposed to LDL. GAPDH was the reference gene, AGE-LDL, oxidized LDL (oxLDL) and native LDL (nLDL) concentration was 100 g/ml and incubation time 24 hrs. Control, cells not exposed to LDL, *P Ͻ 0.05 versus control cells, #P Ͻ 0.05 versus nLDL, n ϭ 3.
above the values obtained for nLDL-exposed cells (126 Ϯ 14) (Fig. 5C) .
Results of the quantification of RAGE mRNA indicated a 10% increase of the gene expression in both LDLs exposed cells compared to control ones, but this was not statistically significant (Fig. 5D ). (Fig. 6A) (Fig. 6C ).
LRP1, CD36 and RAGE protein expression
MCP-1 gene and protein expression
The results obtained by quantitative PCR showed that upon incubation of hSMC with AGE-LDL, the gene expression of MCP-1 increased 1.6-fold (256 Ϯ 35, P Ͻ 0.05) above control
Fig. 4 AGE-LDL induces lipid accumulation in hSMC. The cells were incubated with 100 g/ml AGEL-DL, oxidized LDL (oxLDL) or native LDL (nLDL) for 24 hrs, fixed in 2% formaldehyde and stained with Nile Red (yellow fluorescence). (A) Control, cells not exposed to LDL, (B) cells exposed to nLDL, (C) AGE-LDL and (D) oxLDL; bar
values, whereas the effect of nLDL was significantly lower (158 Ϯ 5) (Fig. 7A) . (Fig. 7B) . In contrast, analysis of the protein expression of MCP-1 in cell lysates revealed no specific band on the Western blot.
A significant increase of MCP-1 protein released in the culture medium was detected after hSMC were incubated with AGE-LDL (215 Ϯ 31, P Ͻ 0.05) compared to nLDL (70 Ϯ 5)
The effect of AGE-LDL on hSMC viability, metabolic competence and proliferation
Viability of hSMC after exposure (24 hrs) to AGE-LDL, nLDL or oxLDL evaluated by the MTT test showed that the cells were not affected by the exposure to either of the LDLs, as compared to the viability of control cells (data not shown).
The (Fig. 8) . [28, 29] 
Discussion
In diabetes, dysfunction of the cells of the vessel wall may be in part the result of their interaction with glycated proteins, such as AGE-LDL, present concurrently in the plasma and in the intima. AGE-LDL is detected both in hyperlipidaemic and hyperglycaemic patients' plasma
. The effect of AGE-LDL on vascular SMC is not known. To detect the alterations generated by AGE-LDL on hSMC, we looked for the NADPHox activity and the intracellular ROS production, the accumulation of lipid droplets and the implication of specific receptors (LRP1, CD36, RAGE), the induction of MCP-1 and the modulation of the proliferation rate.
We chose to incubate the cells with 10 mg AGE-LDL protein/dl culture medium that is in the physiological range (9.3 mg/dl glycated LDL apoB in the serum of patients with diabetes versus 4.8 mg/dl in controls) [28] . Interestingly, Akanji et al. [29] reported that serum-glycated LDL level is increased in patients with hyperlipidaemia without diabetes (6.12 mg/dl) , and further increased in patients with both hyperlipidaemia and diabetes [32] . The p22phox subunit is essential for the NADPHox activity and it was demonstrated [33] that p22phox is more abundant in advanced atherosclerosis plaques than in non-atherosclerotic arteries, suggesting a correlation between p22phox expression, superoxide production and the severity of atherosclerotic lesions. In previous studies, we demonstrated that NF-kB and AP-1 regulate p22phox gene expression in hSMC [34, 35] . The p67phox is regulated also by the same transcription factors [36, 37] [21, 38] . To uncover the possible mechanisms involved 
